Landscape of tumor-infiltrating T cell repertoire of human cancers

Bo Li1,2, Taiwen Li1,3, Jean-Christophe Pignon4, Binbin Wang5, Jinzeng Wang5, Sachet Shukla6, Ruoxu Dou7, Qianming Chen3, F. Stephen Hodi8, Toni K. Choueiri9, Catherine Wu6, Nir Hacohen10, Sabina Signoretti4, Jun S. Liu2, and X. Shirley Liu1,2 1Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA, USA, 2Department of Statistics, Harvard University, Boston, MA, USA, 3State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China, 4Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA, 5School of Life Science and Technology, Tongji University, China, Shanghai, China, 6Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA, 7Department of Colorectal Surgery, Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, 8Center for ImmunoOncology, Harvard Medical School, Boston, MA, USA, 9Kidney Cancer Center, Dana Farber Cancer Institute, Boston, MA, USA, 10Center for Cancer Immunotherapy, Massachusetts General Hospital, Boston, MA, USA